4//SEC Filing
KANEKO YASUNORI 4
Accession 0000899243-18-007986
CIK 0001724521other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 5:26 PM ET
Size
17.7 KB
Accession
0000899243-18-007986
Insider Transaction Report
Form 4
KANEKO YASUNORI
Director
Transactions
- Conversion
Common Stock
2018-03-19+33,818→ 96,948 total(indirect: By Trust) - Conversion
Common Stock
2018-03-19+252,524→ 252,524 total(indirect: By LLC) - Conversion
Series A Convertible Preferred Stock
2018-03-19−505,050→ 0 total(indirect: By LLC)→ Common Stock (505,050 underlying) - Conversion
Series B Convertible Preferred Stock
2018-03-19−252,524→ 0 total(indirect: By LLC)→ Common Stock (252,524 underlying) - Conversion
Common Stock
2018-03-19+505,050→ 505,050 total(indirect: By LLC) - Conversion
Series B Convertible Preferred Stock
2018-03-19−31,253→ 0 total(indirect: By Trust)→ Common Stock (31,253 underlying) - Conversion
Series C Convertible Preferred Stock
2018-03-19−2,565→ 0 total(indirect: By Trust)→ Common Stock (2,565 underlying)
Footnotes (2)
- [F1]The total represents shares received upon conversion of shares of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock.
- [F2]The reported security converted into the Issuer's Common Stock on a 1-for-1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.Q
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001277503
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 5:26 PM ET
- Size
- 17.7 KB